ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

KALV KalVista Pharmaceuticals Inc

10.38
0.03 (0.29%)
Last Updated: 11:58:30
Delayed by 15 minutes

Period:

Draw Mode:

Volume 83,182
Bid Price 10.36
Ask Price 10.38
News -
Day High 10.42

Low
7.21

52 Week Range

High
16.88

Day Low 10.13
Company Name Stock Ticker Symbol Market Type
KalVista Pharmaceuticals Inc KALV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 0.29% 10.38 11:58:30
Open Price Low Price High Price Close Price Prev Close
10.23 10.13 10.42 10.35
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,693 83,182 $ 10.28 $ 854,857 - 7.21 - 16.88
Last Trade Time Type Quantity Stock Price Currency
11:58:58 1 $ 10.3696 USD

KalVista Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
438.76M 42.19M - 0 -92.91M -2.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

KalVista Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No KALV Message Board. Create One! See More Posts on KALV Message Board See More Message Board Posts

Historical KALV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week11.5311.7810.1311.15343,937-1.15-9.97%
1 Month11.0812.455510.1311.50529,313-0.70-6.32%
3 Months15.8116.8810.1313.48831,255-5.43-34.35%
6 Months8.4816.887.2112.62580,9031.9022.41%
1 Year7.9716.887.2111.81405,3532.4130.24%
3 Years24.6130.704.1212.04314,485-14.23-57.82%
5 Years24.0345.004.1216.54288,790-13.65-56.80%

KalVista Pharmaceuticals Description

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States.

Your Recent History

Delayed Upgrade Clock